Researchers in Australia have shown that positron emission tomography that uses a radioactive sugar molecule is more useful than mammography and ultrasound in predicting a breast tumor's response to chemotherapy and, therefore, the patient's ultimate likelihood of survival. The research was presented at the European Cancer Conference in Barcelona today.
Post new comment